Dimski D S, Taboada J
Willamette Veterinary Referral Center, Corvallis, Oregon, USA.
Vet Clin North Am Small Anim Pract. 1995 Mar;25(2):357-73. doi: 10.1016/s0195-5616(95)50031-2.
Feline IHL is a severe hepatopathy that can be treated by aggressive nutritional support. Until the underlying mechanisms of protein and lipid metabolism are understood in both healthy and ill cats, dietary therapy remains supportive. It is likely that the pathogenesis of IHL in cats is multifactorial, involving both increased fatty acid mobilization to the liver and a defect in oxidation of fatty acids or removal of VLDL. It is also possible that individual variation may play a role in the development of this disease in cats undergoing starvation. Continued studies will focus on the unique pathways of hepatic metabolism in the cat, and how these pathways are altered, leading to hepatic lipid accumulation and clinical disease. Hopefully, these studies can be applied to the prevention or treatment of IHL in cats.
猫科动物特发性肝脂沉积症是一种严重的肝病,可通过积极的营养支持进行治疗。在了解健康猫和患病猫的蛋白质及脂质代谢的潜在机制之前,饮食疗法仍起支持作用。猫科动物特发性肝脂沉积症的发病机制可能是多因素的,既涉及脂肪酸向肝脏的动员增加,也涉及脂肪酸氧化或极低密度脂蛋白清除的缺陷。个体差异也可能在饥饿的猫患此病的过程中起作用。持续的研究将聚焦于猫肝脏代谢的独特途径,以及这些途径如何改变,从而导致肝脏脂质蓄积和临床疾病。希望这些研究能够应用于猫科动物特发性肝脂沉积症的预防或治疗。